pfizer glp 1 drug Danuglipron: Pfizer's GLP-1 receptor agonist weight loss pill Pfizer Is Going All In
Description
The FDA approved Rybelsus, an oral version of semaglutide manufactured by the drug company Novo Nordisk, in 2019
We have found a significant and clinically meaningful reduction in ICP in the treatment arm as compared to the placebo arm both acutely and after 12 weeks of dosing
Discussion To our knowledge, this cohort study was the first claims- and EHR-based study comparing both clinical and economic outcomes associated with MBS and GLP-1 RAs for obesity management
Genes Immun
